BI Asset Management Fondsmaeglerselskab’s GSK GSK Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.8M	Buy	911,826 +306,161	+51%	+$16.2M	0.38%	50
2026 Q1	$33.4M	Sell	605,665 -248,666	-29%	-$13.5M	0.35%	57
2025 Q4	$41.9M	Buy	854,331 +814,275	+2,033%	+$38M	0.37%	56
2025 Q3	$1.73M	Sell	40,056 -81,193	-67%	-$3.17M	0.02%	434
2025 Q2	$4.66M	Buy	121,249 +26,685	+28%	+$1.02M	0.05%	263
2025 Q1	$3.66M	Buy	+94,564	New	+$3.46M	0.04%	263

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's GSK Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its GSK (GSK) stake by 51% in Q2 2026, buying an estimated $16.2M and bringing the position to 911,826 shares worth $47.8M. The position accounts for 0.38% of the portfolio, ranked #50.

BI Asset Management Fondsmaeglerselskab first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

BI Asset Management Fondsmaeglerselskab held 911,826 shares of GSK worth $47.8M as of Q2 2026.
BI Asset Management Fondsmaeglerselskab bought 306,161 GSK shares in Q2 2026, an estimated $16.2M.
GSK made up 0.38% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #50 holding.
BI Asset Management Fondsmaeglerselskab first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.